Apollo Hospitals Plans ₹1,254 Crore IFC Stake Acquisition, ₹573 Crore Gurugram Oncology Investment

Apollo Hospitals Enterprise Ltd is set to acquire the 31% stake held by the International Finance Corporation in its subsidiary Apollo Health and Lifestyle Ltd (AHLL) for ₹1,254 crore, making AHLL a nearly 100% subsidiary. This acquisition aims to consolidate ownership, improve operational efficiencies, and allow for sharper capital allocation and disciplined growth across AHLL’s four verticals: primary care and diagnostics, birthing and women's health, ambulatory care, and dialysis and dental services. AHLL reported a consolidated turnover of ₹1,553 crore in FY25 and is expected to play a significant role in Apollo’s integrated healthcare portfolio. Apollo also announced a ₹573 crore investment to establish a state-of-the-art 100-bed oncology center in Gurugram, featuring the Proteus One Proton Beam Therapy system, which will add capacity for 350 patients annually and is part of a broader expansion addressing India’s growing cancer burden. The acquisition and oncology expansion underscore Apollo's focus on high-potential segments and its commitment to innovation and personalized patient care. The transaction is expected to close by November 2025, subject to regulatory approvals.